80_FR_51735 80 FR 51571 - Meeting of the National Vaccine Advisory Committee [email protected] or by calling 202-690-5566 and providing their name, organization, and email address."> [email protected] or by calling 202-690-5566 and providing their name, organization, and email address." /> [email protected] or by calling 202-690-5566 and providing their name, organization, and email address." />

80 FR 51571 - Meeting of the National Vaccine Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 164 (August 25, 2015)

Page Range51571-51572
FR Document2015-20943

As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that the National Vaccine Advisory Committee (NVAC) will hold a meeting September 9-10, 2015. The meeting is open to the public. However, pre- registration is required for both public attendance and public comment. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/upcomingmeetings/. Participants may also register by emailing [email protected] or by calling 202-690-5566 and providing their name, organization, and email address.

Federal Register, Volume 80 Issue 164 (Tuesday, August 25, 2015) 
[Federal Register Volume 80, Number 164 (Tuesday, August 25, 2015)]
[Notices]
[Pages 51571-51572]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-20943]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: National Vaccine Program Office, Office of the Assistant 
Secretary for Health, Office of the Secretary, Department of Health and 
Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a meeting 
September 9-10, 2015. The meeting is open to the public. However, pre-
registration is required for both public attendance and public comment. 
Individuals who wish to attend the meeting and/or participate in the 
public comment session should register at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/. Participants may also register by emailing 
[email protected] or by calling 202-690-5566 and providing their name, 
organization, and email address.

DATES: The meeting will be held on September 9-10, 2015. The meeting 
times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become 
available.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, the Great Hall, 200 Independence Avenue SW., 
Washington, DC 20201.
    The meeting can also be accessed through a live webcast the day of 
the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.

FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. 
Department of Health and Human Services, Room 715-H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 690-5566; email: [email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of Health and 
Human Services was mandated to establish the National Vaccine Program 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The NVAC was established to provide advice and 
make recommendations to the Director of the National Vaccine Program on 
matters related to the Program's responsibilities. The Assistant 
Secretary for Health serves as Director of the National Vaccine 
Program.
    During the September NVAC meeting, the Committee will hear updates 
on a number of Departmental and stakeholder activities that are working 
to strengthen our national immunization system. The Committee will hear 
an update on progress towards the Healthy People 2020 immunization 
goals, followed by presentations specifically examining progress 
towards the Healthy People 2020 goal to achieve 90% influenza 
vaccination coverage among healthcare personnel. In particular, the 
Committee will look at challenges and opportunities for helping improve 
influenza vaccination among healthcare personnel in long-term care 
settings.
    The Committee also will hear about efforts to support global 
immunization including an introduction to a number of global 
immunization strategies currently under development such as an update 
to the CDC's Global Immunization Strategic Framework, the newly 
established USAID Immunization Blueprint for Action, and the Pan 
American Health Organization's proposed Regional Plan of Action on 
Immunization. In addition, the NVAC will hear a brief overview 
describing the success of efforts to develop the first Ebola vaccine.
    The Committee will be presented with information on how data on 
state exemption laws is collected and used to inform studies on 
vaccination coverage and vaccine acceptance in specific populations. 
NVAC will also host a session continuing their discussions on vaccine 
confidence that will include

[[Page 51572]]

studies looking at how attitudes and beliefs about immunizations change 
over time. Finally, the Committee will be provided with information on 
local and federal efforts to help increase vaccine confidence in 
communities. More information on the meeting agenda will be posted 
prior to the meeting on the NVAC Web site: http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the National Vaccine Program Office at the address/phone listed 
above at least one week prior to the meeting. For those unable to 
attend in person, a live webcast will be available. More information on 
registration and accessing the webcast can be found at http://www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/.
    Members of the public will have the opportunity to provide comments 
at the NVAC meeting during the public comment periods designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Individuals are also welcome to submit their written 
comments. Written comments should not exceed three pages in length. 
Individuals submitting written comments should email their comments to 
the National Vaccine Program Office ([email protected]) at least five 
business days prior to the meeting.

    Dated: August 17, 2015.
Jennifer L. Gordon,
Alternate Designated Federal Official, National Vaccine Advisory 
Committee, National Vaccine Program Office.
[FR Doc. 2015-20943 Filed 8-24-15; 8:45 am]
 BILLING CODE 4150-44-P

Federal Register / Vol. 80, No. 164 / Tuesday, August 25, 2015 / Notices 51571 enable HRSA to provide aggregate FORHP’s progress toward meeting the needed to review instructions; to program data required by Congress goals set. develop, acquire, install and utilize under the Government Performance and A 60-day Federal Register Notice was technology and systems for the purpose Results Act (GPRA) of 1993. These published in the Federal Register on of collecting, validating and verifying measures cover the principal topic areas June 1, 2015 (80 FR 31051). There were information, processing and of interest to the Federal Office of Rural no comments. maintaining information, and disclosing Health Policy (FORHP), including: (a) Likely Respondents: The respondents and providing information; to train Access to care; (b) population would be recipients of the Rural personnel and to be able to respond to demographics; (c) staffing; (d) Outreach Benefits Counseling grant a collection of information; to search consortium/network; (e) sustainability; funding. data sources; to complete and review and (f) benefits counseling process and Burden Statement: Burden in this the collection of information; and to outcomes. Several measures will be context means the time expended by transmit or otherwise disclose the persons to generate, maintain, retain, information. The total annual burden used for the Benefits Counseling disclose or provide the information hours estimated for this ICR are Program. All measures will speak to requested. This includes the time summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Average Number of Number of Total burden per Total burden Form name responses per respondents responses response hours respondent (in hours) Rural Outreach Benefits Counseling Grant Program Meas- ures ................................................................................... 10 1 10 2 20 Total .............................................................................. 10 1 10 2 20 Jackie Painter, NVAC Web site at http://www.hhs.gov/ During the September NVAC meeting, Director, Division of the Executive Secretariat. nvpo/nvac/meetings/ the Committee will hear updates on a [FR Doc. 2015–21009 Filed 8–24–15; 8:45 am] upcomingmeetings/ as soon as they number of Departmental and BILLING CODE 4165–15–P become available. stakeholder activities that are working ADDRESSES: U.S. Department of Health to strengthen our national immunization and Human Services, Hubert H. system. The Committee will hear an DEPARTMENT OF HEALTH AND Humphrey Building, the Great Hall, 200 update on progress towards the Healthy HUMAN SERVICES Independence Avenue SW., People 2020 immunization goals, Washington, DC 20201. followed by presentations specifically Meeting of the National Vaccine examining progress towards the Healthy Advisory Committee The meeting can also be accessed People 2020 goal to achieve 90% through a live webcast the day of the AGENCY: National Vaccine Program influenza vaccination coverage among meeting. For more information, visit Office, Office of the Assistant Secretary healthcare personnel. In particular, the http://www.hhs.gov/nvpo/nvac/ for Health, Office of the Secretary, Committee will look at challenges and meetings/upcomingmeetings/. Department of Health and Human opportunities for helping improve FOR FURTHER INFORMATION CONTACT: influenza vaccination among healthcare Services. National Vaccine Program Office, U.S. personnel in long-term care settings. ACTION: Notice. Department of Health and Human The Committee also will hear about SUMMARY: As stipulated by the Federal Services, Room 715–H, Hubert H. efforts to support global immunization Advisory Committee Act, the Humphrey Building, 200 Independence including an introduction to a number Department of Health and Human Avenue SW., Washington, DC 20201. of global immunization strategies Services (HHS) is hereby giving notice Phone: (202) 690–5566; email: nvpo@ currently under development such as an that the National Vaccine Advisory hhs.gov. update to the CDC’s Global Committee (NVAC) will hold a meeting SUPPLEMENTARY INFORMATION: Pursuant Immunization Strategic Framework, the September 9–10, 2015. The meeting is to Section 2101 of the Public Health newly established USAID Immunization open to the public. However, pre- Service Act (42 U.S.C. 300aa–1), the Blueprint for Action, and the Pan registration is required for both public Secretary of Health and Human Services American Health Organization’s attendance and public comment. was mandated to establish the National proposed Regional Plan of Action on Individuals who wish to attend the Vaccine Program to achieve optimal Immunization. In addition, the NVAC meeting and/or participate in the public prevention of human infectious diseases will hear a brief overview describing the comment session should register at through immunization and to achieve success of efforts to develop the first http://www.hhs.gov/nvpo/nvac/ optimal prevention against adverse Ebola vaccine. asabaliauskas on DSK5VPTVN1PROD with NOTICES meetings/upcomingmeetings/. reactions to vaccines. The NVAC was The Committee will be presented with Participants may also register by established to provide advice and make information on how data on state emailing nvpo@hhs.gov or by calling recommendations to the Director of the exemption laws is collected and used to 202–690–5566 and providing their National Vaccine Program on matters inform studies on vaccination coverage name, organization, and email address. related to the Program’s responsibilities. and vaccine acceptance in specific DATES: The meeting will be held on The Assistant Secretary for Health populations. NVAC will also host a September 9–10, 2015. The meeting serves as Director of the National session continuing their discussions on times and agenda will be posted on the Vaccine Program. vaccine confidence that will include VerDate Sep<11>2014 17:10 Aug 24, 2015 Jkt 235001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\25AUN1.SGM 25AUN1

51572 Federal Register / Vol. 80, No. 164 / Tuesday, August 25, 2015 / Notices studies looking at how attitudes and the discussions could disclose DEA, NIDDK, National Institutes of Health, beliefs about immunizations change confidential trade secrets or commercial Room 760, 6707 Democracy Boulevard, over time. Finally, the Committee will property such as patentable material, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. be provided with information on local and personal information concerning and federal efforts to help increase individuals associated with the grant National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; vaccine confidence in communities. applications, the disclosure of which PAR–13–074: Small R03 Grants for New More information on the meeting would constitute a clearly unwarranted Investigators. agenda will be posted prior to the invasion of personal privacy. Date: November 19, 2015. meeting on the NVAC Web site: http:// Name of Committee: National Institute of Time: 11:00 a.m. to 2:00 p.m. www.hhs.gov/nvpo/nvac/meetings/ Diabetes and Digestive and Kidney Diseases Agenda: To review and evaluate grant upcomingmeetings/. Special Emphasis Panel; Small Grants for applications. Public attendance at the meeting is New Investigators. Place: National Institutes of Health, Two limited to the available space. Date: September 8, 2015. Democracy Plaza, 6707 Democracy Individuals who plan to attend and Time: 12:00 p.m. to 4:00 p.m. Boulevard, Bethesda, MD 20892, (Telephone need special assistance, such as sign Agenda: To review and evaluate grant Conference Call). applications. Contact Person: Jian Yang, Ph.D., Scientific language interpretation or other Contact Person: National Institutes of Review Officer, Review Branch, DEA, reasonable accommodations, should Health, Two Democracy Plaza, 6707 NIDDK, National Institutes of Health, Room notify the National Vaccine Program Democracy Boulevard, Bethesda, MD 20892, 755, 6707 Democracy Boulevard, Bethesda, Office at the address/phone listed above (Telephone Conference Call). MD 20892–5452, (301) 594–7799, yangj@ at least one week prior to the meeting. Contact Person: Elena Sanovich, Ph.D., extra.niddk.nih.gov. For those unable to attend in person, a Scientific Review Officer, Review Branch, (Catalogue of Federal Domestic Assistance live webcast will be available. More DEA, NIDDK, National Institutes of Health, Program Nos. 93.847, Diabetes, Room 750, 6707 Democracy Boulevard, information on registration and Bethesda, MD 20892–2542, 301–594–8886, Endocrinology and Metabolic Research; accessing the webcast can be found at 93.848, Digestive Diseases and Nutrition sanoviche@mail.nih.gov. http://www.hhs.gov/nvpo/nvac/ Research; 93.849, Kidney Diseases, Urology Name of Committee: National Institute of and Hematology Research, National Institutes meetings/upcomingmeetings/. Diabetes and Digestive and Kidney Diseases Members of the public will have the of Health, HHS) Special Emphasis Panel; PAR–14–301: opportunity to provide comments at the NIDDK Central Repositories Non-renewable Dated: August 20, 2015. NVAC meeting during the public Sample Access (X01)-Biomarkers for T1D. David Clary, comment periods designated on the Date: September 21, 2015. Program Analyst, Office of Federal Advisory agenda. Public comments made during Time: 2:00 p.m. to 4:00 p.m. Committee Policy. the meeting will be limited to three Agenda: To review and evaluate grant [FR Doc. 2015–21007 Filed 8–24–15; 8:45 am] applications. minutes per person to ensure time is Place: National Institutes of Health, Two BILLING CODE 4140–01–P allotted for all those wishing to speak. Democracy Plaza, 6707 Democracy Individuals are also welcome to submit Boulevard, Bethesda, MD 20892, (Telephone their written comments. Written Conference Call). DEPARTMENT OF HEALTH AND comments should not exceed three Contact Person: Najma Begum, Ph.D., HUMAN SERVICES pages in length. Individuals submitting Scientific Review Officer, Review Branch, written comments should email their DEA, NIDDK, National Institutes of Health, National Institutes of Health Room 749, 6707 Democracy Boulevard, comments to the National Vaccine Bethesda, MD 20892–5452, (301) 594–8894, Program Office (nvpo@hhs.gov) at least Submission for OMB Review; 30-Day begumn@niddk.nih.gov. Comment Request; Surveys To five business days prior to the meeting. Name of Committee: National Institute of Support an Evaluation of the National Dated: August 17, 2015. Diabetes and Digestive and Kidney Diseases Human Genome Research Institute Jennifer L. Gordon, Special Emphasis Panel; PAR–15–067: NIDDK Multi-Center Clinical Study (U01). (NHGRI) Summer Workshop in Alternate Designated Federal Official, Genomics (Short Course) Date: October 6, 2015. National Vaccine Advisory Committee, Time: 3:00 p.m. to 5:00 p.m. National Vaccine Program Office. Agenda: To review and evaluate grant SUMMARY: Under the provisions of [FR Doc. 2015–20943 Filed 8–24–15; 8:45 am] applications. Section 3507(a)(l)(D) of the Paperwork BILLING CODE 4150–44–P Place: National Institutes of Health, Two Reduction Act of 1995, the National Democracy Plaza, 6707 Democracy Institutes of Health (NIH), has submitted Boulevard, Bethesda, MD 20892, (Telephone to the Office of Management and Budget DEPARTMENT OF HEALTH AND Conference Call). (OMB) a request for review and HUMAN SERVICES Contact Person: Dianne Camp, Ph.D., approval of the information collection Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, listed below. This proposed information National Institutes of Health collection was previously published in Room 756, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, 301–594–7682, the Federal Register on March 17, 2015, National Institute of Diabetes and Vol. 80, Page 13845 and allowed 60- campd@extra.niddk.nih.gov. Digestive and Kidney Diseases Notice days for public comment. No public of Closed Meetings Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases comments were received. The purpose Pursuant to section 10(d) of the Special Emphasis Panel; Nutrition Obesity of this notice is to allow an additional asabaliauskas on DSK5VPTVN1PROD with NOTICES Federal Advisory Committee Act, as Research Centers. 30 days for public comment. The amended (5 U.S.C. App.), notice is Date: November 18, 2015. National Human Genome Research Time: 8:00 a.m. to 6:00 p.m. Institute (NHGRI), National Institutes of hereby given of the following meetings. Agenda: To review and evaluate grant The meetings will be closed to the applications. Health, may not conduct or sponsor, public in accordance with the Place: Melrose Hotel, 2430 Pennsylvania and the respondent is not required to provisions set forth in sections Ave. NW., Washington, DC 20037. respond to, an information collection 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Contact Person: Thomas A. Tatham, Ph.D., that has been extended, revised, or as amended. The grant applications and Scientific Review Officer, Review Branch, implemented on or after October 1, VerDate Sep<11>2014 17:10 Aug 24, 2015 Jkt 235001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\25AUN1.SGM 25AUN1


Document Created: 2018-02-23 11:02:47
Document Modified: 2018-02-23 11:02:47
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesThe meeting will be held on September 9-10, 2015. The meeting times and agenda will be posted on the NVAC Web site at http:// www.hhs.gov/nvpo/nvac/meetings/upcomingmeetings/ as soon as they become available.
ContactNational Vaccine Program Office, U.S. Department of Health and Human Services, Room 715-H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690-5566; email: [email protected]
FR Citation80 FR 51571 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR